LibraGen Launches its First Family of Active Products Obtained by Enzymatic Transformation of Natural Substances

LibraGen has announced the availability of its first family of active products obtained through a patented enzymatic process.

The launch of this range marks a step forward for LibraGen as an industry player in its own right for the design and production by biocatalysis of innovative high value-added molecules.

Using its proprietary technology platform, LibraGen has designed an exclusive enzymatic production process to allow the use of naturally derived active molecules which have hitherto proved difficult to exploit because of their physical and chemical properties. This first family of original products is aimed at the cosmetic manufacturers, pharmaceutical industry, and those in the nutrition sector.

This LibraGen's process transforms the raw materials into water-soluble active molecules. These are chemically more stable and have an improved biological availability thus opening up new opportunities to use the compounds for therapeutic, dermo-cosmetic and nutritional applications. This first series of compounds covers a wide and diverse range of biological structures and activities belonging to the polyphenols family.

"The market availability of this first collection of pioneering products is the result of LibraGen's know-how in the development of new enzymatic reactions and the implementation of biocatalytic production processes," said Renaud Nalin, CEO at LibraGen.

"This new range gives a glimpse of the potential we have with our technology and production capabilities as they are all applicable to other active ingredients. Some of our biosynthesized products have already been marketed on a large scale by our customers, and other dedicated product ranges are being produced for marketing in the future by major players in the field of natural products."